Around 300 different species of Artemisia (mugwort, wormwood) are found, mostly in temperate climate zones. Artemisia Annua specifically, has been well known in Chinese folk medicine for the last 2000 years. Only recently has it come to the attention of researcher’s because of its potent anti-malarial properties. Efficacy against Malaria and Plasmodium The main ingredient of the plant is Artemisinin, a patented malaria drug, which is manufactured mostly in China and India. It is considered to be one of the best drugs against malaria, but as with all single substance drugs a few cases of drug resistance have been reported. Yet, if one makes use of a plant extract, drug resistance is practically impossible, because the plant contains more than 9 agents which are effective against malaria. The malaria parasite ‘Plasmodium’ is a single-celled parasite which in contrast to bacteria has a cell nucleus. One cannot develop resistance against a volley of several concomitant substances, which is surely not the case with mono-substances. Unfortunately, the pharmaceutical industry works almost exclusively with mono-substances, and therefore several good anti-malarial drugs are now almost useless. There is a high risk that this could happen to Artemisinin. The efficacy of Artemisia Annua against malaria has been confirmed by hundreds if not thousands of testimonies worldwide, people who have been healed from malaria just by using this plant extract. Through a simple plant called Artemisia annua, the poorest people in Africa – who cannot afford expensive drugs – can be helped effectively. No resistance by taking the unprocessed plant It is important to know that with the use of the Artemisia Annua plant worldwide, no known cases of drug resistance have occurred and probably will not occur because of the biological interaction of the 10 different substances. In the case of malaria it is therefore important to use the complete plant extract and not only a drug. The clinical cure rate for malaria is 90% to 95 %, the patient is healthy even though the plasmodium may remain in the blood asymptomatically. ![]() The plant Artemisia Annua is very well researched. Apart from Arteminsinin, a further 245 different substances have already been identified and isolated, including numerous anti-inflammatory polyphenols. In contrast to most drugs, to date almost no side effects have been reported. The only contra-indications are for people suffering with stomach ulcers and/or stomach acid. Efficacy against cancer Observations have been made with Malaria patients who were using Artemisia Annua who also suffered with other serious diseases such as AIDS and cancer. Amazingly, these diseases have improved significantly during the treatment with Artemisia Annua. In fact, there are already many scientific studies which indicate successes. On the website of the U.S. national library of medicine (www.ncbi.nlm.nih.gov/pubmed) 497 general studies and 51 studies on cancer are listed on Artemisia Annua. Memorial Sloan-Kettering, attested distinct anti-cancer properties in vitro to this plant (www.mskcc.org/cancer-care/herb/artemisia-annua). Yet, to advertise the plant as a miracle cure would be frivolous. Further tests are necessary. Artemisia – how it works ![]() ![]() There is even strong evidence that suggests viruses can be fought with Artemisia Annua, especially in the early stages of a disease. Among the cured malaria patients, there were those who also suffered with AIDS. In these cases the disease was improved and in some cases even cured. The anti-viral qualities of Artemisia Annua are demonstrated by the following studies: www.ncbi.nlm.nih.gov/pubmed/16902856 / www.cid.oxfordjournals.org/content/47/6/804.full In my personal environment I get feedback from friends who take Artemisia ground powder at the first sign of a cold / flu and feel in perfect health again the next day. These reports are encouraging, but there is not yet a scientific basis to support the claim. Antibacterial effect There is now evidence of an effect against bacteria yet the evidence is still sparse. There are observations of anti-bacterial properties in vitro on gram-positive and gram-negative bacteria. Slightly better is the data available on leishmaniasis and the African sleeping sickness, caused by protozoa, which however is not applicable in a European context. Artemisia Annua can have a preventive or curative effect on the following:
Phytomedicine. 2011 Aug 15;18(11):959-69. Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin. Efferth T, Herrmann F, Tahrani A, Wink M. Artemisia annua L. (sweet wormwood, qinhao) has traditionally been used in Chinese medicine. The isolation of artemisinin from Artemisia annua and its worldwide accepted application in malaria therapy is one of the showcase success stories of phytomedicine during the past decades. Artemisinin-type compounds are also active towards other protozoal or viral diseases as well as cancer cells in vitro and in vivo. Nowadays, Artemisia annua tea is used as a self-reliant treatment in developing countries. The unsupervised use of Artemisia annua tea has been criticized to foster the development of artemisinin resistance in malaria and cancer due to insufficient artemisinin amounts in the plant as compared to standardized tablets with isolated artemisinin or semisynthetic artemisinin derivatives. However, artemisinin is not the only bioactive compound in Artemisia annua. In the present investigation, we analyzed different Artemisia annua extracts. Dichloromethane extracts were more cytotoxic (range of IC₅₀: 1.8-14.4 μg/ml) than methanol extracts towards Trypanosoma b. brucei (TC221 cells). The range of IC₅₀ values for HeLa cancer cells was 54.1-275.5 μg/ml for dichloromethane extracts and 276.3-1540.8 μg/ml for methanol extracts. Cancer and trypanosomal cells did not reveal cross-resistance among other compounds of Artemisia annua, namely the artemisinin-related artemisitene and arteanuine B as well as the unrelated compounds, scopoletin and 1,8-cineole. This indicates that cells resistant to one compound retained sensitivity to another one. These results were also supported by microarray-based mRNA expression profiling showing that molecular determinants of sensitivity and resistance were different between artemisinin and the other phytochemicals investigated. Is it safe? Toxicology Artemisinin derived drugs are available for the treatment of malaria. Except for two case reports, no major side effects have been reported in humans at doses used for the treatment of malaria but it is still unknown whether the higher doses required for the treatment of cancer patients could cause major side effects. In vivo studies showed that doses of artemisinin-related endoperoxides of at least 5 times higher than those used for antimalaria therapy are required in order to induce an effect. The safety of such doses has not yet been evaluated in Phase I clinical trials. A first case report describes a boy who received artesunate suppositories and died 13 days.25 He had received a dose 7-fold higher than the maximum recommended dose which reportedly led to toxicity of the brain stem. In a second case report a woman with recently resected early breast carcinoma described symptoms of toxic brainstem encephalopathy.26 Since this neurotoxicity has also been seen in animals, the authors of the case report ascribe the toxicity to artemisinin consumption, although she received also chemotherapy and a mixture of other herbs on top. On the other hand, a review of the toxicity of artemisinin derivatives suggested that the toxicity seen in laboratory animals does not necessarily occur in humans due to the differences in pharmacokinetic profile after different routes of administration. The oral administration used in humans is unlikely to cause the neurotoxicity seen after intramuscular administration in mice. Adverse events It has been reported that the oral intake of A. annua may cause abdominal pain, bradycardia (abnormally slow heartbeat), diarrhoea, nausea, vomiting, decreased appetite, flu-like symptoms, fever, and decreased reticulocyte count. Topical application of A. annua may cause dermatitis. Interactions Experimental studies showed additive or synergistic activities with antineoplastics, antibiotics, antifungals, sodium butyrate, and chloroquine, where it could become more effective in fever subsidence and disappearance of malarial symptoms.7 References
Legal notice The present documentation has been compiled by the CAM-CANCER Project with all due care and expert knowledge. However, the CAM-CANCER Project provides no assurance, guarantee or promise with regard to the correctness, accuracy, up-to-date status or completeness of the information it contains. This information is designed for health professionals. Readers are strongly advised to discuss the information with their physician. Accordingly, the CAM-CANCER Project shall not be liable for damage or loss caused because anyone relies on the information. Artemisia annua - Pharmacology and Biotechnology. Tariq Aftab,Jorge F.S. Ferreira,M. Masroor A. Khan,M. Naeem J Ethnopharmacol. 2012 Jun 14;141(3):854-9. doi: 10.1016/j.jep.2012.03.024. Epub 2012 Mar 24. Ethnopharmacology in overdrive: the remarkable anti-HIV activity of Artemisia annua. Lubbe A1, Seibert I, Klimkait T, van der Kooy F. Artemisia annua contains the well-known antimalarial compound artemisinin, which forms the backbone of the global malaria treatment regime. In African countries a tea infusion prepared from Artemisia annua has been used for the treatment of malaria only for the past 10-20 years. Several informal claims in Africa exist that the Artemisia annua tea infusions are also able to inhibit HIV. Since HIV is a relatively newly emerged disease, the claims, if substantiated, could provide a very good example of "ethnopharmacology in overdrive". The objective of this study was to provide quantitative scientific evidence that the Artemisia annua tea infusion exhibits anti-HIV activity through in vitro studies. A second objective was to determine if artemisinin plays a direct or indirect (synergistic) role in any observed activity. This was done by the inclusion of a chemically closely related species, Artemisia afra, known not to contain any artemisinin in our studies. MATERIALS AND METHODS: Validated cellular systems were used to test Artemisia annua tea samples for anti-HIV activity. Two independent tests with different formats (an infection format and a co-cultivation format) were used. Samples were also tested for cellular toxicity against the human cells used in the assays. RESULTS: The Artemisia annua tea infusion was found to be highly active with IC(50) values as low as 2.0 μg/mL. Moreover we found that artemisinin was inactive at 25 μg/mL and that a chemically related species Artemisia afra (not containing artemisinin) showed a similar level of activity. This indicates that the role of artemisinin, directly or indirectly (synergism), in the observed activity is rather limited. Additionally, no cellular toxicity was seen for the tea infusion at the highest concentrations tested. CONCLUSION: This study provides the first in vitro evidence of anti-HIV activity of the Artemisia annua tea infusion. We also report for the first time on the anti-HIV activity of Artemisia afra although this was not an objective of this study. These results open the way to identify new active pharmaceutical ingredients in Artemisia annua and thereby potentially reduce the cost for the production of the important antimalarial compound artemisinin. |